Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
KOREA E & EX

Events

18 Feb 2016 - 20 Feb 2016
24 Feb 2016 - 26 Feb 2016

Medtronic to Acquire Covidien for USD 42.9 billion

By HospiMedica International staff writers
Posted on 16 Jun 2014
Print article
Medtronic, Inc. (Minneapolis, MN, USA), a global leader in medical technology, services and solutions, and Covidien plc (Dublin, Ireland), a global healthcare technology and medical supplies provider, announced that they have entered into a definitive agreement under which Medtronic has agreed to acquire Covidien in a cash-and-stock transaction valued at USD 93.22 per Covidien share, or a total of approximately USD 42.9 billion.

The deal creates a medical technology and services company with a comprehensive product portfolio and broad global reach that is better able to improve healthcare outcomes, and meaningfully accelerates Medtronic's core strategies. The combined revenue is expected to reach USD 27 billion, including USD 3.7 billion from emerging markets.

After the completion of the transaction, the businesses of Medtronic and Covidien will be combined under a new entity to be called Medtronic plc. It will have its principal executive offices in Ireland, where Covidien's current headquarters resides and where both companies have a longstanding presence. Medtronic plc will be led by Omar Ishrak, and will continue to have its operational headquarters in Minneapolis, where Medtronic currently employs more than 8,000 people.

Once the transaction is completed, Medtronic will have significantly advanced its position as the world's premier medical technology and services company. The combined company will have a comprehensive product portfolio, a diversified growth profile and broad geographic reach, with 87,000 employees in more than 150 countries. The boards of directors of both companies have unanimously approved the transaction.

As a direct benefit of the company's new financial structure, Medtronic will commit to USD 10 billion in technology investments over the next 10 years in areas such as early stage venture capital investments, acquisitions and R&D in the US, above and beyond Medtronic's and Covidien's existing plans.

"We are excited to reach this agreement with Covidien, which further advances our mission to alleviate pain, restore health and extend life for patients around the world," said Omar Ishrak, chairman and CEO of Medtronic. "This acquisition will allow Medtronic to reach more patients, in more ways and in more places. Our expertise and portfolio of services will allow us to serve our customers more efficiently and better address the demands of the current healthcare marketplace. We also look forward to welcoming the Covidien team to Medtronic and working together to improve healthcare outcomes globally."

"Covidien and Medtronic, when combined, will provide patients, physicians and hospitals with a compelling portfolio of offerings that will help improve care and surgical performance," said José E. Almeida, chairman, president and CEO of Covidien. "This transaction provides our shareholders with immediate value and the opportunity to participate in the significant upside potential of the combined organization. I'd like to thank our 38,000 employees whose hard work and dedication has enabled Covidien to deliver innovative health solutions that improve patient outcomes."

Related Links:
Covidien
Medtronic



Print article
LevMed LTD.

Channels

Surgical Techniques

view channel

Nerve Cap Facilitates Management of Symptomatic Neuromas

An innovative device reduces painful neuroma formation, facilitating tissue repair and regeneration following nerve resection. Neurocap is a transparent tubular bioresorbable polymer cap that serves as a synthetic nerve covering. It was designed to help treat symptomatic neuromas by isolating the nerve stump from surrounding... Read more

Women's Health

view channel
Image: The Eclipse vaginal insert in deflated (L) and Inflated (R) states (Phoyo courtesy of Pelvalon).

Vaginal Insert Offers Alternative Treatment for Fecal Incontinence

A novel vaginal insert for bowel control eliminates the need for surgery or an in-office procedure for the treatment of female fecal incontinence (FI). The second-generation Eclipse System is comprised... Read more

Health IT

view channel
Image: The sweat sensor in a prototype flexible plastic wristband (Photo courtesy of Wei Gao et al., Nature).

Wearable Sensor Could Monitor Dehydration and Fatigue

A fully integrated electronic system that can continuously monitor multiple sweat chemicals could be incorporated into wristbands and headbands, according to a new study. The prototype device, developed... Read more

Hospital News

view channel

Geneia Partners with Hospitals on Population Health Training

Geneia (Harrisburg, PA, USA) will provide population health management training to members of the Illinois Health and Hospital Association (IHA; Chicago, USA). Through its education arm, The Geneia Institute, skills-based population health management programs will be delivered to IHA's 209 hospital and nearly 50 health... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.